NICE recommends routine NHS funding for new breast cancer drugs
Sign Up to like & getrecommendations! Published in 2017 at "British Medical Journal"
DOI: 10.1136/bmj.j5309
Abstract: The new breast cancer drugs palbociclib (Ibrance, Pfizer) and ribociclib (Kisqali, Novartis) should be routinely funded on the NHS, draft guidance from the National Institute for Health and Care Excellence (NICE) has recommended. The guidance,1… read more here.
Keywords: cancer drugs; new breast; breast; breast cancer ... See more keywords
What’s new in breast pathology 2022: WHO 5th edition and biomarker updates
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Pathology and Translational Medicine"
DOI: 10.4132/jptm.2022.04.25
Abstract: The 5th edition WHO Classification of Breast Tumours (2019) has introduced changes to our practices. Highlights are presented below, with a focus on modifications to morphological subtype categorization. In addition, we summarize important updates to… read more here.
Keywords: new breast; breast; pathology; 5th edition ... See more keywords